Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP474337.RAyehVSO5gFnbF380wAq8CVjZtbAPpTwxZklEJcZrEg4M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP474337.RAyehVSO5gFnbF380wAq8CVjZtbAPpTwxZklEJcZrEg4M130_assertion type Assertion NP474337.RAyehVSO5gFnbF380wAq8CVjZtbAPpTwxZklEJcZrEg4M130_head.
- NP474337.RAyehVSO5gFnbF380wAq8CVjZtbAPpTwxZklEJcZrEg4M130_assertion description "[We have studied, using monoclonal antibodies for immunohistochemistry, the Id1 and Id3 tumor epithelial expression in 17 patients with stage III-N2 non-small cell lung cancer (NSCLC) treated with definitive chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP474337.RAyehVSO5gFnbF380wAq8CVjZtbAPpTwxZklEJcZrEg4M130_provenance.
- NP474337.RAyehVSO5gFnbF380wAq8CVjZtbAPpTwxZklEJcZrEg4M130_assertion evidence source_evidence_literature NP474337.RAyehVSO5gFnbF380wAq8CVjZtbAPpTwxZklEJcZrEg4M130_provenance.
- NP474337.RAyehVSO5gFnbF380wAq8CVjZtbAPpTwxZklEJcZrEg4M130_assertion SIO_000772 23311395 NP474337.RAyehVSO5gFnbF380wAq8CVjZtbAPpTwxZklEJcZrEg4M130_provenance.
- NP474337.RAyehVSO5gFnbF380wAq8CVjZtbAPpTwxZklEJcZrEg4M130_assertion wasDerivedFrom befree-20150227 NP474337.RAyehVSO5gFnbF380wAq8CVjZtbAPpTwxZklEJcZrEg4M130_provenance.
- NP474337.RAyehVSO5gFnbF380wAq8CVjZtbAPpTwxZklEJcZrEg4M130_assertion wasGeneratedBy ECO_0000203 NP474337.RAyehVSO5gFnbF380wAq8CVjZtbAPpTwxZklEJcZrEg4M130_provenance.